BioLineRx Ltd Blog | Talkmarkets

Latest Posts

3 Small Cap Biotechs With Upcoming Catalysts

Article By: Scott Matusow

Monday, October 1, 2018 8:21 PM EST

Catalyst Trading in biotech stocks can be very profitable. Often times, many catalyst events are over looked by the market, especially when it comes to small cap biotech.

In this article: AFMD, BLRX, SNDX Also: BMY, FPRX

Read

Week In Review: Xynomic Signs $502 Million Deal For Boehringer's RAF Inhibitor

Article By: ChinaBio® Today

Saturday, November 4, 2017 4:58 PM EST

Xynomic Pharma, a US-Shanghai clinical-stage oncology drug developer, acquired exclusive global rights to a 2nd-generation RAF inhibitor from Boehringer Ingelheim. Xynomic, hoping BI 882370 is a best-in-class drug, agreed to a $502 million package.

In this article: BLRX, ILMN, TEVA, NAVB Also: INTC, BABA

Read

E Trump's Kvittle

Article By: Vivian Lewis

Tuesday, May 23, 2017 12:24 AM EST

The President should not be blamed for all the fall in our currency, because even before he hit the scene the US$ was up way over trend, and near its 1985 peak. To revive industry, as Trump proposes, he needs a cheaper currency.

In this article: , ALV, CZZ, F, GSK, MXE, TTM, VALE, VOD, CH, ANCUF, AQUNF, BKSHF, CGRIF, CMDXF, DLKGF, NPSNY, OROCF, PPEHF, TCTZF, BLRX, SHPG, TEVA, CGEN, CUBA, INPCF, BNTC, BNTCW

Read

Week In Review: Week's Deals Create New China Life Science Alliances

Article By: ChinaBio® Today

Saturday, August 27, 2016 5:14 PM EST

Almost a half billion dollars in deals were worked out in the China biotech space last week, the largest being Luye Medical Group's commitment of $300 million to bring up-to-date healthcare to a large healthcare complex.

In this article: BLRX, DHRM

Read